Antipsychotic Polypharmacy: Is There Evidence for its Use?

@article{Patrick2005AntipsychoticPI,
  title={Antipsychotic Polypharmacy: Is There Evidence for its Use?},
  author={Vijayalakshmy Patrick and E. Levin and S. Schleifer},
  journal={Journal of Psychiatric Practice},
  year={2005},
  volume={11},
  pages={248-257}
}
Antipsychotic polypharmacy occurs frequently in clinical practice; however, there is a lack of controlled clinical studies testing the efficacy of the combinations used. The purpose of this literature review was to examine studies and other reports that have assessed the incremental benefits and deficits of combination antipsychotic therapy versus monotherapy. A PUBMED search covering a 26-year period from 1976 to 2002 was conducted. The search was limited to clinical trials, case series, and… Expand
Aripiprazole in Treatment-refractory Schizophrenia
Combination antipsychotic therapy in psychiatric outpatient clinics in Taiwan.
...
1
2
3
4
...

References

SHOWING 1-10 OF 84 REFERENCES
Polypharmacy among psychiatric patients
Limitations of controlled augmentation trials in schizophrenia
Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study.
...
1
2
3
4
5
...